Archive Newsletter

31. 04.08.26 -- Ensuring Quality Of CGT Materials 4/8/2026
    04/08/26
32. 04.07.26 -- Aseptic Insights & Automation 4/7/2026
    04/07/26 Cell & Gene Newsletter
33. 04.07.26 -- Rethinking ATMP Assurance When Sterility Timelines, Reality Misalign 4/7/2026
    04/07/26
34. 04.07.26 -- STREAM Edition: Regulatory Flexibility In CGT: Key Shifts And Implications With Monika Swietlicka 4/7/2026

    04/07/26 Cell & Gene Newsletter

35. 04.06.26 -- New Podcast Episodes: Regenerative Skin Therapy, Orally Available Biologics, Regulatory Flexibility In CGT, and More 4/6/2026
    04/06/26 Cell & Gene Newsletter
36. 04.06.26 -- February 2026 — CDMO Opportunities And Threats Report 4/6/2026
    04/06/26 Cell & Gene Newsletter
37. 04.03.26 -- Zymeworks Shares Its Design Rationale (And Wins) In Early-Phase ADC Trials 4/3/2026
    04/03/26 Cell & Gene Newsletter
38. 04.02.26 -- Navigating GMP Biosafety Challenges In ATMP Manufacturing 4/2/2026
    04/02/26 Cell & Gene Newsletter
39. 04.01.26 -- The In Vivo Cell Therapy Shift On Display At PMWC 2026 4/1/2026
    04/01/26 Cell & Gene Newsletter
40. 03.31.26 -- STREAM Edition: Take The Lead With A GS Cell Line Development Kit 3/31/2026

    03/31/26 Cell & Gene Newsletter